Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» US FDA approves Antares' oxybutynin gel for overactive bladder treatment
US FDA approves Antares' oxybutynin gel for overactive bladder treatment
US FDA approves Antares' oxybutynin gel for overactive bladder treatment
Submitted by
admin
on December 10, 2011 - 1:21pm
Source:
Pharmabiz
News Tags:
Antares Pharma
oxybutynin gel
overactive bladder
Headline:
US FDA approves Antares' oxybutynin gel for overactive bladder treatment
Do Not Allow Advertisers to Use My Personal information
